Many stakeholders play a role in ensuring access for patients; providers in community and academic settings, leaders at infusion clinics, decision makers within IDNs, health plans, trade and distribution, officials from regulatory/HTA agencies, professional societies, compendia organizations, and advocacy organizations. Innovation Partners’ deep expertise in oncology, hematology, and rare disease guides creation of a custom and comprehensive map16 of individuals and organizations who have the capacity to impact access, coverage, and reimbursement for your portfolio. Whether you are bringing your first product to market, or entering a new therapeutic area, our team will leverage our deep relationships with influencers to identify the key decision makers you need to engage to ensure future success.